A — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-06-01

• Pending Acquisition. On March 6, 2026, we entered into a definitive agreement to acquire 100 percent of the outstanding capital stock of BC Midco I, Inc. (“Biocare”) for an aggregate purchase price of approximately $950 million in cash. Biocare is a leading provider of clinical and research solution…

• Global Tariffs. On February 20, 2026, the U.S. Supreme Court invalidated certain tariffs imposed under the International Emergency Economic Powers Act (“IEEPA”), and the U.S. Court of International Trade ordered U.S. Customs and Border Protection (“CBP”) to refund such tariffs, subject to potential …

• While tariffs remain dynamic, we have mitigated the adverse impact related to our cost of revenue during the three and six months ended April 30, 2026 through our continued mitigation strategies such as supply chain optimization, targeted pricing actions, and other cost-efficiency initiatives to pro…

• Middle East Conflict. The recent escalation of geopolitical tensions in the Middle East and surrounding regions has increased global economic uncertainty and disruptions to global energy supply chains resulting in inflationary pressures. The Middle East conflict did not have a material impact on our…

• Net revenue of $1,835 million and $3,633 million for the three and six months ended April 30, 2026 increased 10 percent and 8 percent, respectively, when compared to the same periods last year. The overall effect of foreign currency movements on revenue growth for the three and six months ended Apri…

Text removed vs the prior filing · source: 10-Q · 2026-03-03

• Global Tariffs. While the tariff changes adversely impacted our costs of revenue during the three months ended January 31, 2026, we expect to fully offset the current impact during our fiscal year 2026. Although the tariff situation is still evolving, we expect to pursue mitigation strategies throug…

• Net revenue of $1,798 million for the three months ended January 31, 2026 increased 7 percent when compared to the same period last year. The overall effect of foreign currency movements on revenue growth for the three months ended January 31, 2026 had a 3 percentage point favorable impact when comp…

• overall effect of foreign currency movements on revenue growth for the three months ended January 31, 2026, had a 3 percentage point favorable impact when compared to the same period last year.

• Net income for the three months ended January 31, 2026 was $305 million compared to net income of $318 million for the corresponding period last year. In the three months ended January 31, 2026, cash provided by operations was $268 million compared to cash provided by operations of $431 million in t…

• Dividends. During the three months ended January 31, 2026, we paid cash dividends of $0.255 per common share or $72 million on the company's common stock. During the three months ended January 31, 2025, we paid cash dividends of $0.248 per common share or $71 million on the company's common stock.

Text added vs the prior filing · source: 10-Q · 2026-06-01

• Our operations generate non-functional currency cash flows such as revenue, third party vendor payments and inter-company payments. In anticipation of these foreign currency cash flows and in view of volatility of the currency market, we enter into such foreign exchange contracts as are described ab…

• We performed a sensitivity analysis assuming a hypothetical 10 percent adverse movement in foreign exchange rates to the hedging contracts and the underlying exposures described above. As of April 30, 2026, the analysis indicated that these hypothetical market movements would not have a material eff…

Text removed vs the prior filing · source: 10-Q · 2026-03-03

• Our operations generate non-functional currency cash flows such as revenue, third party vendor payments and inter-company payments. In anticipation of these foreign currency cash flows and in view of volatility of the currency market, we enter into such foreign exchange contracts as are described ab…

• The overall effect of changes in foreign currency exchange rates had a 3 percentage point favorable impact on revenue growth in the three months ended January 31, 2026 principally as a result of the relative strength of the U.S. dollar. We calculate the impact of movements in our foreign currency ex…

• We performed a sensitivity analysis assuming a hypothetical 10 percent adverse movement in foreign exchange rates to the hedging contracts and the underlying exposures described above. As of January 31, 2026, the analysis indicated that these hypothetical market movements would not have a material e…

Text added vs the prior filing · source: 10-Q · 2026-06-01

• In addition, geopolitical instability, including conflicts in the Middle East, and evolving trade regulations, including tariffs, sanctions, and export controls, may restrict our ability to ship products globally or source critical components. These

• developments can increase costs, disrupt supply chains, and require operational adjustments. Failure to comply with these regulations could result in penalties, loss of export privileges, and reputational harm.

• Additionally, our business operations related to our product sales to customers receiving funding from the U.S. federal government could be impacted by a lack of appropriations of additional funding to federal agencies. Inadequate funding for government agencies, including from government shutdowns,…

• investments and alliances, consolidate results, including losses, of third parties or write down investment values or loans and convertible notes related to the strategic investment.

• will be able to prevent future significant deficiencies or material weaknesses. Inadequate internal controls could cause investors to lose confidence in our reported financial information, which could have a negative effect on investor confidence in our financial statements, the trading price of our…

Text removed vs the prior filing · source: 10-Q · 2026-03-03

• In addition, geopolitical instability and evolving trade regulations, including tariffs, sanctions, and export controls, may restrict our ability to ship products globally or source critical components. These developments can increase costs, disrupt supply chains, and require operational adjustments…

• Additionally, our business operations related to our product sales to customers receiving funding from the U.S. federal government could be impacted by lack of appropriations of additional funding to federal agencies. Inadequate funding for government agencies, including from government shut downs, …

• financial statements, the trading price of our stock and our access to capital.

• A number of our products and services are subject to regulation by the Food and Drug Administration, the U.S. Department of Health and Human Services, the Centers for Medicare & Medicaid Services and certain similar foreign regulatory agencies. In addition, a number of our products and services may …